Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Siracusano

Showing results (161-170 of 190) with videos related to

Pageof 19
Sort By:
Brain Stimulation|September 16, 2023
Corrigendum to "Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine" [Brain Stimul 16 (2023)]Mauro Pettorruso, Giacomo d'Andrea, Francesco Di Carlo, et al.
Brain Stimulation|June 18, 2023
Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamineMauro Pettorruso, Giacomo d'Andrea, Francesco Di Carlo, et al.
Frontiers in Psychiatry|January 30, 2023
Family functioning and personal growth in Italian caregivers living with a family member affected by schizophrenia: Results of an add-on study of the Italian network for research on psychosesRita Roncone, Laura Giusti, Valeria Bianchini, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 24, 2016
Anti-GAPDH Autoantibodies as a Pathogenic Determinant and Potential Biomarker of Neuropsychiatric DiseasesFederica Delunardo, Denise Soldati, Veronica Bellisario, et al.
Schizophrenia Research|January 15, 2022
Joint structural-functional magnetic resonance imaging features are associated with diagnosis and real-world functioning in patients with schizophreniaLinda A Antonucci, Leonardo Fazio, Giulio Pergola, et al.
Journal of Clinical Medicine|December 24, 2021
Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life FunctioningGiulia M Giordano, Luigi Giuliani, Andrea Perrottelli, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 8, 2023
Cognitive impairment after recovery from COVID-19: Frequency, profile, and relationships with clinical and laboratory indicesSilvana Galderisi, Andrea Perrottelli, Luigi Giuliani, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 27, 2017
Assessment of de novo copy-number variations in Italian patients with schizophrenia: Detection of putative mutations involving regulatory enhancer elementsGiulio Piluso, Palmiero Monteleone, Silvana Galderisi, et al.
Early Intervention in Psychiatry|October 15, 2020
Which factors delay treatment in bipolar disorder? A nationwide study focussed on duration of untreated illnessMassimiliano Buoli, Bruno Mario Cesana, Andrea Fagiolini, et al.
Schizophrenia Research|May 23, 2016
Pathways to functional outcome in subjects with schizophrenia living in the community and their unaffected first-degree relativesSilvana Galderisi, Alessandro Rossi, Paola Rocca, et al.
Pageof 19

Showing results (161-170 of 190) with videos related to

Sort By:
Pageof 19
Brain Stimulation|September 16, 2023
Corrigendum to "Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine" [Brain Stimul 16 (2023)]Mauro Pettorruso, Giacomo d'Andrea, Francesco Di Carlo, et al.
Brain Stimulation|June 18, 2023
Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamineMauro Pettorruso, Giacomo d'Andrea, Francesco Di Carlo, et al.
Frontiers in Psychiatry|January 30, 2023
Family functioning and personal growth in Italian caregivers living with a family member affected by schizophrenia: Results of an add-on study of the Italian network for research on psychosesRita Roncone, Laura Giusti, Valeria Bianchini, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 24, 2016
Anti-GAPDH Autoantibodies as a Pathogenic Determinant and Potential Biomarker of Neuropsychiatric DiseasesFederica Delunardo, Denise Soldati, Veronica Bellisario, et al.
Schizophrenia Research|January 15, 2022
Joint structural-functional magnetic resonance imaging features are associated with diagnosis and real-world functioning in patients with schizophreniaLinda A Antonucci, Leonardo Fazio, Giulio Pergola, et al.
Journal of Clinical Medicine|December 24, 2021
Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life FunctioningGiulia M Giordano, Luigi Giuliani, Andrea Perrottelli, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 8, 2023
Cognitive impairment after recovery from COVID-19: Frequency, profile, and relationships with clinical and laboratory indicesSilvana Galderisi, Andrea Perrottelli, Luigi Giuliani, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 27, 2017
Assessment of de novo copy-number variations in Italian patients with schizophrenia: Detection of putative mutations involving regulatory enhancer elementsGiulio Piluso, Palmiero Monteleone, Silvana Galderisi, et al.
Early Intervention in Psychiatry|October 15, 2020
Which factors delay treatment in bipolar disorder? A nationwide study focussed on duration of untreated illnessMassimiliano Buoli, Bruno Mario Cesana, Andrea Fagiolini, et al.
Schizophrenia Research|May 23, 2016
Pathways to functional outcome in subjects with schizophrenia living in the community and their unaffected first-degree relativesSilvana Galderisi, Alessandro Rossi, Paola Rocca, et al.
Pageof 19